Abstract:Introduction: Dynamic contrast-enhanced (DCE) MRI has important clinical value for early detection, accurate staging, and therapeutic monitoring of cancers. However, conventional multi-phasic abdominal DCE-MRI has limited temporal resolution and provides qualitative or semi-quantitative assessments of tissue vascularity. In this study, the feasibility of retrospectively quantifying multi-phasic abdominal DCE-MRI by using pharmacokinetics-informed deep learning to improve temporal resolution was investigated. Method: Forty-five subjects consisting of healthy controls, pancreatic ductal adenocarcinoma (PDAC), and chronic pancreatitis (CP) were imaged with a 2-s temporal-resolution quantitative DCE sequence, from which 30-s temporal-resolution multi-phasic DCE-MRI was synthesized based on clinical protocol. A pharmacokinetics-informed neural network was trained to improve the temporal resolution of the multi-phasic DCE before the quantification of pharmacokinetic parameters. Through ten-fold cross-validation, the agreement between pharmacokinetic parameters estimated from synthesized multi-phasic DCE after deep learning inference was assessed against reference parameters from the corresponding quantitative DCE-MRI images. The ability of the deep learning estimated parameters to differentiate abnormal from normal tissues was assessed as well. Results: The pharmacokinetic parameters estimated after deep learning have a high level of agreement with the reference values. In the cross-validation, all three pharmacokinetic parameters (transfer constant Ktrans, fractional extravascular extracellular volume ve, and rate constant kep) achieved intraclass correlation coefficient and R2 between 0.84-0.94, and low coefficients of variation (10.1%, 12.3%, and 5.6%, respectively) relative to the reference values. Significant differences were found between healthy pancreas, PDAC tumor and non-tumor, and CP pancreas. Discussion: Retrospective quantification (RoQ) of clinical multi-phasic DCE-MRI is possible by deep learning. This technique has the potential to derive quantitative pharmacokinetic parameters from clinical multi-phasic DCE data for a more objective and precise assessment of cancer.

Direct Estimation of Pharmacokinetic Parameters from DCE-MRI using Deep CNN with Forward Physical Model Loss

Unpaired Deep Learning for Pharmacokinetic Parameter Estimation from Dynamic Contrast-Enhanced MRI

Joint Optimization of k-t Sampling Pattern and Reconstruction of DCE MRI for Pharmacokinetic Parameter Estimation

Normalizing Flow-Based Distribution Estimation of Pharmacokinetic Parameters in Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Accelerated Brain Tumor Dynamic Contrast‐enhanced MRI Using Adaptive Pharmaco‐Kinetic Model Constrained Method

Estimation of the Capillary Level Input Function for Dynamic Contrast-Enhanced MRI of the Breast Using a Deep Learning Approach

Unpaired deep learning for pharmacokinetic parameter estimation from dynamic contrast-enhanced MRI without AIF measurements

Retrospective quantification of clinical abdominal DCE-MRI using pharmacokinetics-informed deep learning: a proof-of-concept study

Improving the pharmacokinetic parameter measurement in dynamic contrast-enhanced MRI by use of the arterial input function: theory and clinical application.

Deep Learning Quantification of Vascular Pharmacokinetic Parameters in Mouse Brain Tumor Models.

Fully-automated deep learning-powered system for DCE-MRI analysis of brain tumors

Temporo-Spatial Collaborative Filtering for Parameter Estimation in Noisy DCE-MRI Sequences: Application to Breast Cancer Chemotherapy Response

Dynamic Contrast Enhanced (DCE) MRI Estimation of Vascular Parameters Using Knowledge-Based Adaptive Models

Tracer Kinetic Models as Temporal Constraints during DCE-MRI reconstruction

Gaussian process inference for estimating pharmacokinetic parameters of dynamic contrast-enhanced MR images

Accelerated Reconstruction of Perfusion-Weighted MRI Enforcing Jointly Local and Nonlocal Spatio-temporal Constraints

A Bayesian framework for pharmacokinetic modelling in dynamic contrast-enhanced magnetic resonance cancer imaging

A Bayesian hierarchical framework for pharmacokinetic modelling in dynamic contrast-enhanced magnetic resonance cancer imaging

Scan-Specific Unsupervised Highly Accelerated Non-Cartesian CEST Imaging Using Implicit Neural Representation and Explicit Sparse Prior

Deep Cardiac MRI Reconstruction with ADMM

Spatiotemporal Flexible Sparse Reconstruction for Rapid Dynamic Contrast-enhanced MRI